Tuesday, September 8, 2026

ContextLogic Acquires gChem (LOGC): Update and Valuation

ContextLogic will acquire specialty-solvent maker gChem for $850 million, funded by a $650 million rights offering and $250 million of debt, expanding Abrams Capital’s acquisition platform.

LOGC $682M

Hidden Gems Investing Sep 8 4 clicks

Sep 8 LULU $11B

Lululemon: Deep Dive Analysis

Hated Moats 6 clicks

Sep 7 TRV $75B

P&C Stocks Worth Owning: The AI Hedge with Ryan Tunis | The Real Eisman Playbook Episode 74

Steve Eisman 6 clicks

From X

@leevalueroach Sep 8

Lee Roach on X

Once again an awful day to be a 200-IQ $BUR holder

@ACapitalLP Sep 8

A Capital on X

$VRRM *

@BlueDuckCap Sep 8 1 click

BDC on X

Elon commenting on Spiegel’s post - first time that’s ever happened. Maybe it’s something. Probably not anything. But add it to the mosaic. $snap https://t.co/ofuZxr4UK7

@ActAccordingly Sep 8

PAA Research on X

@TopCornerInvest Thanks. It wasn't based on the quarter. There's more to go here. $MUSA $CASY

@TidefallCapital Sep 8

Trevor Scott on X

$FICO could have just kept quiet and slowly raised prices. Instead they jacked it up 17x over 5 years and lost their 30 year monopoly. 'Anyone that has a monopoly will pretend that they're in incredible competition.' - Peter Thiel https://t.co/fCCphiaSox

@TimyanBankAlert Sep 8

Timyan Bank Alert on X

The Pipeline: Blue Ridge $BRBS worked to shore up its business between two sale offers | S&P Global Market Intelligence https://t.co/nfapDdBkkI

@DOMOCAPITAL Sep 8 1 click

DOMO Capital Management, LLC on X

$GME 👀 https://t.co/o0cx17NM88

@TidefallCapital Sep 8

Trevor Scott on X

@ValueInvestShow fashion cyclicality has destroyed many value investors! revenue is quickly decelerating and ebit margins are double a decade ago! not a single insider purchase in this 63% drawdown $DECK

WD #357: Tecnoglass/Tariffs, Colombia Mining Boom?, Airports & Airlines

Tecnoglass could recover tariff- and FX-hit margins as U.S. blanket tariffs on Colombian goods lift.

TGLS $1.6B

Ian’s Insider Corner Sep 7 3 clicks

Scholar Rock: Manufacturing Noise Obscures A Muscle-Targeted Franchise

Scholar Rock’s apitegromab could become the first muscle-targeted SMA therapy by September 2026, but manufacturing setbacks and a…

SRRK $6.2B

Equity Eagle Sep 7

Celsius: The Pepsi Put

Celsius holds 20% of the U.S. energy-drink market and 40% of sugar-free sales, but its $1.65 billion Alani acquisition complicates…

CELH $7.1B

TSOH Investment Research Sep 7 7 clicks

On Holding $ONON: I Bought the Shoes First, Then the Stock

On Holding $ONON combines a high-margin direct-to-consumer footwear model with replacement-driven demand, after Q2 2026 sales rose 21.6%…

ONON $9.9B

Substack von Philipp Sep 7 5 clicks

National Vision Holdings: Higher Ticket Prices Can't Mask Falling Foot Traffic

National Vision Holdings' 2.2% same-store sales growth masked a 4.9% transaction decline, while inventory rose 37% and deferred marketing…

EYE $1.3B

Number Cruncher Sep 7 1 click

Titan Mining Q2 Update

Titan Mining reported Q2 revenue of $25.7 million and adjusted EBITDA of $9.6 million as zinc output rose, while advancing its Kilbourne…

TII $309M

Sylence Capital Sep 6 4 clicks

Preview of the Week Ahead: W/C September 7, 2026

U.S. CPI and PPI headline the September 7 week as the S&P 500 holds key averages, Bitcoin faces $82,000 resistance and gold tests its…

COIN $51B

SixSigmaCapital: Navigating the Financial Markets Sep 6 2 clicks

The Fed Is Going to Lose the Bond Market and I Found the Asset That Gets Paid When It Does

Rayonier’s 4.0 million acres are valued at $393 an acre after other assets, versus $1,200 to $1,800 cutover-land sales, framing the timber…

RYN $6B

The Value Road Sep 4 27 clicks

TSOH Weekly Roundup (09/04/2026)

TSOH Weekly Roundup covers Costco’s $4.99 chicken supply chain, Celsius’s 20% energy-drink share, and California utilities’ wildfire…

CELH $7.1B

TSOH Investment Research Sep 4 5 clicks

The Afterburners Could Kick In Soon On Southwest Airlines Stock - Rating Upgrade

Southwest Airlines is adding ancillary fees, assigned seating and premium products after a 6.7% Q2 adjusted operating margin, targeting up…

LUV $20B

Tim Dunn Sep 4

PERF · long

Perfect CORP

Perfect Corp., a Taiwan-based beauty-tech microcap SPAC, trades below net cash despite sales growth after falling from a brief $2 billion…

PERF $197M

Value Investors Club May 22

IOFNF- Iofina (buy)

Iofina’s IO10 iodine plant is due in Q3 2024, adding 100 to 150 metric tons of capacity while higher brine costs pressure earnings.

IOFNF $107M

Sylence Capital Apr 28

A 4x in 4 Years Surfing the Data Center Tsunami? ($TSSI)

Total Site Solutions ($TSSI) depends on Dell for 96% of revenue; the 4x thesis rests on Dell expanding modular data centers amid AI-driven…

TSSI $253M

Multibagger Monitor Apr 16 4 clicks

A Mexican Blue Chip Bargain

Grupo Herdez, a MXN 15.2 billion Mexican food company, pairs dominant grocery brands with McCormick, Barilla and Hormel joint ventures.

GUZOF $985M

Exploring with Alluvial Capital Mar 7

Nvidia, Nano-X and the interpretation of 13F filings

Nvidia’s $380,000 Nano-X stake came from Zebra Medical Vision’s acquisition and is managed by another reporting person, undermining the 50%…

NNOX $69M

John Hempton's Newsletter Feb 15 2 clicks

Quality Investing Outside the Blue Chips

Rand Worldwide, an Autodesk reseller, grew revenue from $116 million to $306 million while using less equity; expired three-year…

RWWI $400M

Exploring with Alluvial Capital Dec 26

Sarepta Risk and the FDA

Sarepta’s Exondys 51 approval despite a 12-patient trial frames FDA regulatory risk and a call to remove Commissioner Robert Califf.

SRPT $2.2B

John Hempton's Newsletter Oct 31 1 click

A Value Trap, an Ancient Stock Pitch, a Glimpse Into The Past

Four Corners’ insider-backed asset sale cut shareholder proceeds to roughly 80% of its prior share price. A 2016 Wilh.

FCPT $2.7B

Exploring with Alluvial Capital Sep 27

Does anyone remember when Alnylam went up 50 percent in a day on a phase three result

Alnylam’s 2022 50% phase-three gain faces FDA advisory-panel scrutiny over its amyloidosis drug’s label extension.

ALNY $33B

John Hempton's Newsletter Sep 12

Tuesday, September 8, 2026

ContextLogic Acquires gChem (LOGC): Update and Valuation

Lululemon: Deep Dive Analysis

P&C Stocks Worth Owning: The AI Hedge with Ryan Tunis | The Real Eisman Playbook Episode 74

From X

Lee Roach on X

A Capital on X

BDC on X

PAA Research on X

Trevor Scott on X

Timyan Bank Alert on X

DOMO Capital Management, LLC on X

Trevor Scott on X

Investor Letters

WD #357: Tecnoglass/Tariffs, Colombia Mining Boom?, Airports & Airlines

Scholar Rock: Manufacturing Noise Obscures A Muscle-Targeted Franchise

Celsius: The Pepsi Put

On Holding $ONON: I Bought the Shoes First, Then the Stock

National Vision Holdings: Higher Ticket Prices Can't Mask Falling Foot Traffic

Titan Mining Q2 Update

Preview of the Week Ahead: W/C September 7, 2026

The Fed Is Going to Lose the Bond Market and I Found the Asset That Gets Paid When It Does

TSOH Weekly Roundup (09/04/2026)

The Afterburners Could Kick In Soon On Southwest Airlines Stock - Rating Upgrade

Perfect CORP

IOFNF- Iofina (buy)

A 4x in 4 Years Surfing the Data Center Tsunami? ($TSSI)

A Mexican Blue Chip Bargain

Nvidia, Nano-X and the interpretation of 13F filings

Quality Investing Outside the Blue Chips

Sarepta Risk and the FDA

A Value Trap, an Ancient Stock Pitch, a Glimpse Into The Past

Does anyone remember when Alnylam went up 50 percent in a day on a phase three result

Publications we follow

YouTube 4

Blogs 12

Seeking Alpha 30 of 163

X accounts we follow

Investor letters we follow

Sectors

Tuesday, September 8, 2026

Lee Roach on X

A Capital on X

BDC on X

PAA Research on X

Trevor Scott on X

Timyan Bank Alert on X

DOMO Capital Management, LLC on X

Trevor Scott on X

Investor Letters

Publications we follow

Newsletters 91

YouTube 4

Blogs 12

Seeking Alpha 30 of 163

X accounts we follow

Investor letters we follow

Sectors